SOFTIN TABLET (LORATADINE) 10mg PACK OF 10 COATED TABLETS: Relief from Allergic Symptoms and More

Introduction:

SOFTIN tablets and syrup are a trusted solution for
individuals seeking relief from allergic rhinitis, chronic urticaria, and other
allergy-related dermatological conditions. With loratadine as its active
ingredient, this medication offers potent and long-lasting relief from symptoms
associated with allergies. In this comprehensive guide, we’ll delve into the
composition, pharmacokinetics, indications, and precautions associated with
SOFTIN TABLET, ensuring you have all the necessary information for safe and effective
use

Composition:

Each film-coated tablet of SOFTIN contains 10 mg of
loratadine. The syrup version, SOFTIN 5 mg/5 ml, contains loratadine in a 5 mg
per 5 ml concentration

Description:

Loratadine, the active ingredient in SOFTIN, is a highly
effective and long-acting antihistamine with selective peripheral H1 receptor antagonist activity. Its chemical structure is ethyl 4(8chloro5,6dihydro11Hbenzo[5,6]cyclohepta[1,2b]pyridin11ylidene)1piperidinecarboxylate,
with an empirical formula of C22H23ClN2O2 and a molecular weight of 382.88

Pharmacokinetics:

 Loratadine is well absorbed and extensively metabolized. It
rapidly reaches measurable levels in the bloodstream within 15 minutes, with
peak levels achieved approximately one hour after a single oral dose. Its
elimination half-life ranges from 18 to 24 hours. Importantly, the
administration of loratadine can be done with or without food, as food does not
significantly affect its pharmacokinetics. Studies have demonstrated that
chronic renal insufficiency and alcoholic liver disease do not significantly alter
the pharmacokinetics of loratadine

Indications:

SOFTIN (Loratadine) tablets and syrup are indicated for the
relief of symptoms associated with allergic rhinitis, including sneezing, nasal
discharge (rhinorrhea), itching, ocular itching and burning. Additionally, it
is effective in managing chronic urticaria and other dermatological conditions
related to allergies

Contraindications:

Loratadine is contraindicated in individuals who have
displayed hypersensitivity or idiosyncratic reactions to any of its components

Possible Adverse Effects:

Loratadine is generally well tolerated, with few reported
side effects. It does not typically induce sedation or anticholinergic effects.
Fatigue, sedation, headache, nausea, and dry mouth have been reported but are
rare.

 Drug Interactions:

Loratadine does not potentiate the effects of alcohol.
However, it is advisable to discontinue antihistamines, including loratadine,
approximately four days prior to skin testing procedures, as these drugs may
interfere with or diminish otherwise positive reactions to dermal reactivity
indicators

Warnings:

Loratadine should be prescribed with caution during
pregnancy and lactation, as its safety has not been fully established under
these conditions

Dosage & Administration:

•  Children &
  Adolescents (Over 12 years of age): SOFTIN 10 mg tablets or SOFTIN syrup (2
  teaspoonfuls) once daily
•  Children (2 to 12
  years of age):
•    Body weight over 30 kg: SOFTIN 10 mg tablets
  or SOFTIN syrup (2 teaspoonfuls) once daily
•    Body weight 30 kg or below: Not recommended
•  Adults (including
  older people): SOFTIN 10 mg tablets or SOFTIN syrup (2 teaspoonfuls) once daily
  or as advised by the physician
• For individuals with severe liver problems, consultation
  with a physician is advisable

Storage/Precautions:

Store SOFTIN tablets in a cool, dry, and dark place between
1530 °C (5986 °F) and SOFTIN syrup between 1525 °C (5977 °F). Keep all medicines out
of the reach of children

Presentation:

SOFTIN 10 mg tablets are available in packages containing 10
filmcoated tablets, while SOFTIN 5 mg/5 ml syrup is available in bottles
containing approximately 60 ml